Simon Liang

Simon Liang

Novartis Institutes for BioMedical Research - Bhubaneswar / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4452666
-
person_outline Simon Liang's MOST POPULAR ARTICLES
1-) Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptorL Ma, T Dichwalkar, JYH Chang, B Cossette, D Garafola, AQ Zhang, ...Science 365 (6449), 162-168, 20192052019
2-) Peptide amphiphile micelles self-adjuvant group A streptococcal vaccinationA Trent, BD Ulery, MJ Black, JC Barrett, S Liang, Y Kostenko, NA David, ...The AAPS journal 17 (2), 380-388, 2015992015
3-) Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stabilityKD Moynihan, RL Holden, NK Mehta, C Wang, MR Karver, J Dinter, ...Cancer immunology research, canimm. 0607.2017, 2018372018
4-) SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanismsY Wang, M Mohseni, A Grauel, JE Diez, W Guan, S Liang, JE Choi, M Pu, ...Scientific Reports 11 (1399), 2021542021
5-) Modular peptide amphiphile micelles improving an antibody-mediated immune response to group A streptococcusJC Barrett, BD Ulery, A Trent, S Liang, NA David, MV TirrellACS biomaterials science & engineering 3 (2), 144-152, 2017502017